Aprea Therapeutics (APRE) Q2 2025 Earnings

May 14Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.72
-0.64
-0.57
-0.49

Details

Expected EPS
-0.6543
Actual EPS
-0.66
Surprise EPS
-0.01
Surprise Percent
-0.87%

Description

⁨Aprea Therapeutics⁩ (⁦APRE⁩) has reported earnings of ⁦-0.66⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts